Moderna MRNA
NASDAQ MRNA
$145.53 -3.34 (-2.24%)
As of: Sep 4, 2026 · 3:59 PM EDT

Moderna (MRNA) EBT Margin (QoQ) (2018 - 2026)

Analysis

Moderna (MRNA) EBT Margin (QoQ) (2018 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Incyte 25.44 Bn 20.91 Bn 1.57 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -18,603.00
Mar 31, 2026 -22,508.00
Dec 31, 2025 -9,944.00
Sep 30, 2025 55,765.00
Jun 30, 2025 31,654.00
Mar 31, 2025 -77,003.00
Dec 31, 2024 -12,370.00
Sep 30, 2024 53,183.00
Jun 30, 2024 16,690.00
Mar 31, 2024 -70,010.00
Dec 31, 2023 10,943.00
Sep 30, 2023 40,149.00
Jun 30, 2023 -49,205.00
Mar 31, 2023 -4,893.00
Dec 31, 2022 -362.00
Sep 30, 2022 -1,592.00
Jun 30, 2022 -1,762.00
Mar 31, 2022 -531.00
Dec 31, 2021 354.00
Sep 30, 2021 113.00